According to the U.S. Preventive Services Task Force (USPSTF), colorectal cancer is the third leading cause of cancer death for both men and women, with an estimated 52,980 individuals in the U.S. projected to die from the disease in 2021. After evaluating the current evidence and conducting a modeling study, USPSTF updated its recommendations on colorectal cancer screening.
In May 2021, the National Academy of Medicine released its next iteration of the Future of Nursing report: 2020–2030: Charting a Path to Achieve Health Equity. In it, the academy calls for nurses to lead a stronger, more diversified workforce to promote health and well-being to their colleagues, patients, and communities and to address the structural racism and systemic inequities that have fueled widespread health disparities.
On June 30, 2021, the U.S. Food and Drug Administration (FDA) approved asparaginase erwinia chrysanthemi (recombinant)-rywn (RylazeTM) as a component of a multiagent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) in adult and pediatric patients one month or older who have developed hypersensitivity to E. coli-derived asparaginase.
Nursing is a calling, but sometimes the profession takes nurses into careers that are an opportunity to serve others without direct patient care. In a recent blog post, Patricia Flatley Brennan, RN, PhD, director of the National Institute of Health’s (NIH) National Library of Medicine, looked back at the roles she’s held. Brennan considered herself a “mother-daughter-sister-aunt-friend, and an advocate for self-care management education and support for all people.” But on top of it all, she is a nurse.
Sofia is a 35-year-old patient who identifies as female who was recently diagnosed with breast cancer and is concerned with experiencing chemotherapy-induced alopecia (CIA) as an adverse event from treatment. She comes in for her first infusion of adriamycin plus cyclophosphamide and is using scalp cooling to prevent hair loss. She works as a project manager, which requires her to keep her camera on for her many daily video calls.
Social distancing was never intended to be social isolation, but many of us have struggled to maintain relationships in today’s world. Human beings are built to be social, and science has shown that building strong, meaningful relationships can get us through tough times, provide physical and mental advantages, and make us happier. Perhaps a silver lining of the pandemic is a newfound appreciation for social connections with friends, colleagues, and community.
Approximately 31 million Americans now have healthcare coverage through the Affordable Care Act (ACA), according to a June 2021 issue brief from the office of the assistant secretary for planning and evaluation (ASPE). Of those, 11.3 million consumers were enrolled in Marketplace plans, 14.8 million people were newly enrolled in Medicaid, 1 million individuals were enrolled in ACA’s Basic Health Program option, and nearly 4 million previously eligible adults gained coverage under the Medicaid expansion due to enhanced outreach and increased federal funding.
Patients with uveal melanoma who were treated with tebentafusp, an investigational immunotherapy, lived a median 5.7 months longer than those in comparison groups, researchers reported in study findings presented at the American Association for Cancer Research 2021 annual meeting.
ONS Director-at-Large Anne Ireland, MSN, RN, AOCN®, CENP, and executive director of City of Hope’s Clinical Network and Outreach Nursing Department in Duarte, CA, was among the 12 San Gabriel Valley, CA, women on the frontlines of the COVID-19 coronavirus pandemic to whom U.S. Representative Judy Chu (D-CA) dedicated the 2021 Congressional Woman of the Year award. The recipients were nominated for their extraordinary community service and leadership during the pandemic.
Tepotinib (Tepmetko®) was granted accelerated approval in February 2021 for mesenchymalepithelial transition (MET)-altered metastatic non-small cell lung cancer (NSCLC) based on overall response rate and duration. The drug is still under long-term evaluation and healthcare providers should report all serious adverse events that may be associated to FDA’s MedWatch Reporting System.